retatrutide first week 🚨The phase 3 trial, TRIUMPH-4, top-line data announced today 🚨 💉 Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis 📉 28.7% weight loss at 68 Retatrutide—A Game Changer in Obesity
Pay in 4 interest-free payments of $6.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

























